Medtech company Bone Index has announced the successful close of its latest financing round and a new strategic partnership with Lynx Financial. This collaboration is set to enhance Bone Index’s distribution and service capabilities across North America and the Asia Pacific regions, allowing the company to meet the increasing demand for its bone health diagnostic solutions in these key markets. The funding, led by Lynx Financial and supported by other European investors and existing shareholders, will be used to scale Bone Index’s operations and infrastructure.
The company’s flagship solution Bindex is a portable point-of-care device designed to assess bone mineral density and provide reliable estimates of osteoporosis risk. The device measures the cortical bone thickness of the tibia, achieving a 90% accuracy rate comparable to traditional DXA scans, making it a valuable tool in both early screening and various orthopedic treatment settings. The Bindex system has already achieved early commercialization and adoption in Europe and the U.S., and this partnership aims to further extend its reach.
Osteoporosis is a critical health issue, especially for women, who are disproportionately affected by the condition. Approximately 80% of people with osteoporosis are women, largely due to the hormonal changes that occur during menopause, which accelerate bone density loss. Despite this, osteoporosis remains underdiagnosed, with many women not receiving timely screening or treatment. The Bindex system’s ability to provide rapid, accurate, and non-invasive diagnostics could play a crucial role in addressing this gap, particularly by enabling early diagnosis and intervention for at-risk populations.
Janne Karjalainen, CEO of Bone Index, shared: “This investment and partnership with Lynx Financial are pivotal steps in our growth journey. The funds will significantly enhance our distribution and service capabilities in North America and Asia Pacific, allowing us to bring our state-of-the-art bone health diagnostics to a larger audience.”
Tero Silvola, Chairman of Bone Index, commented: “We are thrilled to have Lynx Financial join us as a partner. Their extensive experience in business development, particularly in the healthcare sector, will be invaluable as we expand our operations.”
Donald Xu, Managing Director of Lynx Financial aadded: “Bone Index’s solution is accurate and accessible and can democratize the way osteoporosis is detected and diagnosed. We believe Bone Index is poised for significant growth and market penetration.”
